Sage Therapeutics Jumps on Biogen’s $469 Million Takeover Offer

Estimated read time 1 min read


Shares of Sage Therapeutics Inc. surged after Biogen Inc. offered to acquire the neuroscience-focused drugmaker for about $469 million.

Source link

You May Also Like

More From Author

+ There are no comments

Add yours